◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › SNYR

Synergy CHC Corp. (SNYR) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Distribution · DATA UPDATED 2026-07-13

Synergy CHC Corp. (SNYR) operates in the Medical Distribution industry and is headquartered in Windham, United States with about 28 employees. Its market capitalization is roughly $3 million. In the fiscal year ended 2025-12-31, SNYR reported $30M in revenue and ($12M) in net income.

Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, Mexico, and internationally.

Interactive charts & full statements → Open the SNYR valuation workbench →

SNYR Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-31
Total Revenue$30M$35M$43M
Gross Profit$20M$24M$32M
Operating Income (EBIT)($2M)$6M$11M
Net Income($12M)$2M$6M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SNYR Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$6M$6M$8M$8M$8M
Gross Profit$4M$2M$6M$6M$6M
Operating Income (EBIT)($1M)($7M)$1M$2M$2M
Net Income($3M)($15M)$0M$2M$1M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SNYR Free Cash Flow History

SNYR Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-31
Total Assets$10M$16M$12M
Total Liabilities$33M$33M$40M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SNYR viewer.

Other Companies in Medical Distribution

← SNXAll stocksSO →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.